Literature DB >> 12226048

Effects of chronic episodic hypoxia on rat upper airway muscle contractile properties and fiber-type distribution.

Michelle McGuire1, Mary MacDermott, Aidan Bradford.   

Abstract

OBJECTIVE: Contraction of upper airway (UA) muscles such as the geniohyoids and sternohyoids dilates and/or stabilizes the UA, thereby maintaining its patency. Obstructive sleep apnea (OSA) is caused by episodes of UA collapse, and this results in chronic episodic hypoxia. Chronic continuous hypoxia affects skeletal muscle structure and function, but the effects of chronic episodic hypoxia on UA muscle structure and function are unknown.
DESIGN: Rats were exposed to alternating periods of hypoxia and normoxia twice per minute for 8 h/d for 5 weeks in order to mimic the intermittent hypoxia of OSA in humans. Isometric contractile properties were determined using strips of isolated geniohyoid and sternohyoid muscles in physiologic saline solution at 30 degrees C. Fiber-type distribution was determined using adenosine triphosphatase staining.
RESULTS: Chronic episodic hypoxia had no significant effect on twitch or tetanic tension, twitch/tetanic tension ratio, contractile kinetics, tension-frequency relationship, or fiber-type distribution for either the sternohyoid or geniohyoid muscle. However, chronic episodic hypoxia did significantly increase sternohyoid and geniohyoid fatigue and reduced recovery from fatigue.
CONCLUSIONS: Chronic episodic hypoxia increases UA muscle fatigue, an effect that may compromise the maintenance of UA patency.

Entities:  

Mesh:

Year:  2002        PMID: 12226048     DOI: 10.1378/chest.122.3.1012

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Differential expression of lipid and carbohydrate metabolism genes in upper airway versus diaphragm muscle.

Authors:  Erik van Lunteren; Sarah Spiegler; Michelle Moyer
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

2.  Metabolic activity of the tongue in obstructive sleep apnea. A novel application of FDG positron emission tomography imaging.

Authors:  Andrew M Kim; Brendan T Keenan; Nicholas Jackson; Eugenia L Chan; Bethany Staley; Drew A Torigian; Abass Alavi; Richard J Schwab
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

Review 3.  Potential therapeutic targets in obstructive sleep apnoea.

Authors:  Julian P Saboisky; Nancy L Chamberlin; Atul Malhotra
Journal:  Expert Opin Ther Targets       Date:  2009-07       Impact factor: 6.902

4.  In-situ mechanical characteristics of the tongue are not altered in the obese Zucker rat.

Authors:  Andrew D Ray; Gaspar A Farkas; David R Pendergast
Journal:  Sleep       Date:  2009-07       Impact factor: 5.849

5.  Diaphragm muscle remodeling in a rat model of chronic intermittent hypoxia.

Authors:  Christine M Shortt; Anne Fredsted; Aidan Bradford; Ken D O'Halloran
Journal:  J Histochem Cytochem       Date:  2013-05-02       Impact factor: 2.479

6.  Chronic intermittent hypoxia increases rat sternohyoid muscle NADPH oxidase expression with attendant modest oxidative stress.

Authors:  Robert Williams; Paul Lemaire; Philip Lewis; Fiona B McDonald; Eric Lucking; Sean Hogan; David Sheehan; Vincent Healy; Ken D O'Halloran
Journal:  Front Physiol       Date:  2015-01-30       Impact factor: 4.566

7.  Modulation of Muscle Fiber Compositions in Response to Hypoxia via Pyruvate Dehydrogenase Kinase-1.

Authors:  Daniel D Nguyen; Gyuyoup Kim; Eung-Kwon Pae
Journal:  Front Physiol       Date:  2016-12-15       Impact factor: 4.566

Review 8.  Respiratory muscle dysfunction in animal models of hypoxic disease: antioxidant therapy goes from strength to strength.

Authors:  Ken D O'Halloran; Philip Lewis
Journal:  Hypoxia (Auckl)       Date:  2017-07-14

9.  A new device to mimic intermittent hypoxia in mice.

Authors:  Kamil J Chodzyński; Stephanie Conotte; Luc Vanhamme; Pierre Van Antwerpen; Myriam Kerkhofs; J L Legros; Michel Vanhaeverbeek; Alain Van Meerhaeghe; Gregory Coussement; Karim Zouaoui Boudjeltia; Alexandre Legrand
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.